India, April 24 -- Molbio Diagnostics Limited, a pioneer in point-of-care molecular diagnostics, recently unveiled their latest innovation, Truenat HPV-HRPlus, which enables expanded high-risk genotype detection.

The chip-based RT-PCR test allows rapid and decentralized detection of eight high-risk genotypes of human papillomavirus (HPV) -which account for over 96% of cervical cancer cases globally.

The multicentric validation was supported by the Grand Challenges India, Biotechnology Industry Research Assistance Council (BIRAC)and theDepartment of Biotechnology (DBT), Government of India under its program "Validating Indigenous Human Papilloma Virus (HPV) Tests for Cervical Cancer Screening in India", making it one of the most trusted,...